Biotech policy, regulations & bioethics form the foundational framework that ensures responsible innovation in biotechnology. As advances in genetic editing, synthetic biology, and personalized medicine accelerate, regulatory agencies and global policymakers face the challenge of balancing innovation with public safety and ethical integrity. This field encompasses the formulation of guidelines governing clinical trials, intellectual property, environmental release, and cross-border biotech trade. Bioethics plays a critical role in addressing concerns surrounding genome editing, data privacy, consent in biobanking, and equity in access to biotech products. Biotech policy, regulations & bioethics ensure transparency, accountability, and societal trust while facilitating global collaboration. A well-regulated landscape not only protects public interests but also accelerates adoption of life-enhancing technologies in healthcare, agriculture, and the environment.
Title : Renewed novel biotech ideas, with bioreactor bioengineering economic impact
Murray Moo Young, University of Waterloo, Canada
Title : Osmotic lysis–driven Extracellular Vesicle (EV) engineering
Limongi Tania, University of Turin, Italy
Title : Steps and strides: Cross-species insights into movement and injury
Babak Faramarzi, Western University of Health Sciences, United States
Title : Eliminating implant failure in humans with nano chemistry: 45,000 cases and counting
Thomas J Webster, Brown University, United States
Title : Scientist’s computational lawyer
Julia Sidorova, Instituto Carlos III de Salud (CIBER-EHD), Spain
Title : Evaluating cell compatibility and subcutaneous host response of silk fibroin–chitosan plug composites as potential resorbable implants
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico